Bruna Pellini: Why should we study circulating tumor DNA

Bruna Pellini shared a post on LinkedIn:

“Why should we study circulating tumor DNA (ctDNA)?

Discover how my research on ctDNA aims to uncover cancer drivers, enable earlier diagnosis, and pave the way for new treatments Moffitt Cancer Center, Moffitt Oncology Network.”

Proceed to the video attached to the post.
Source: Bruna Pellini/LinkedIn

More posts by Bruna Pellini on oncodaily.com

Bruna Pellini is an Assistant Professor at the University of South Florida and an Assistant Member in the Department of Thoracic Oncology at Moffitt Cancer Center. Her research centers on the use of liquid biopsies to monitor treatment response, detect minimal residual disease (MRD), and integrate these techniques into clinical trials.